Huiyi Zhu | Head of US PM/Global Line Manager for Viral Vector
ProBio (CDMO)

Huiyi Zhu, Head of US PM/Global Line Manager for Viral Vector, ProBio (CDMO)

Huiyi Zhu is the Head of U.S. Project Management and Global Line Manager for Viral Vector Business at ProBio Inc., bringing over 13 years of extensive experience in the development and GMP manufacturing of advanced therapy medicinal products, including plasmids and viral vectors. He has led end-to-end technical operations across multiple CGT platforms, encompassing upstream and downstream processing, fill-finish, packaging design, and global technology transfer. His track record includes successful IND and BLA submissions across numerous biologics and CGT commercial programs, and he played a direct role in the commercialization of Zolgensma during his tenure at AveXis/Novartis Gene Therapy. At ProBio, he leads the U.S. project management organization, supporting global CGT CDMO operations by driving technical strategy, establishing integrated platforms, and designing CMC solutions to accelerate clients’ path to clinical and commercial success.

Appearances:



Day 2: 18th March 2026 @ 11:30

Advancing In Vivo CAR-T Therapies: CDMO Strategies Integrating LVV Delivery and mRNA-tLNP Platforms

last published: 12/Dec/25 13:55 GMT

back to speakers


Get Involved with Advanced Therapies Congress

 

To sponsor or exhibit

Ashlea Foster
ashlea.foster@terrapinn.com
+44 208 164 3032

 

To speak

Chris Shanks
Chris.Shanks@terrapinn.com
+44 207 092 1150